Lea en español

Xarelto (chemical name Rivaroxaban) is an anti-coagulant manufactured by Bayer typically prescribed for people who are at risk for nonhemorrhagic strokes or embolisms. It has also been FDA approved for use during total knee or hip replacement surgery, as well as non-valvular atrial fibrillation. The FDA first approved Rivaroxaban for use in the United States in 2011.
Because it is an anticoagulant, Xarelto poses a serious risk of uncontrolled bleeding, including internal bleeding. At present, there is no known way to reverse the effects of Xarelto, which may be active for 8-12 hours. The FDA has also received reports of liver toxicity tied to use of Xarelto and has required that the package contain a warning not to discontinue without talking to a physician, as the likelihood of stroke can increase dramatically.
If you or someone you love has suffered injury after using Xarelto, GetLegal has the tools and resources to help you find skilled legal representation to protect your rights. Visit our attorney directory, look for your geographic location and find the best lawyer for your situation.

Defective Drugs & Medical Devices Topics

Latest Articles

Four Types of Professional Malpractice

When you hear the word “malpractice,” what’s the first image that comes to mind? A doctor perf…

14 Dec 2018, Friday

Sacred Sites and Ski Resorts: The Hopi Tribe and Reclaimed Wastewater

What constitutes a “public nuisance”? And does an injury rooted in religious belief override gen…

13 Dec 2018, Thursday

Field Test Fail: When Traffic Stops Go Wrong

Traffic stops on New Year’s Eve may be a good way of deterring drunk driving, but a pair of Georgi…

12 Dec 2018, Wednesday